(Reuters) -Several pharmaceutical companies have said they will sell drugs direct to patients in the U.S. and offered ...

For its third quarter, Crinetics earned $143,000 in revenue, derived fully from a licensing agreement with Japanese ...

Weight-loss therapy drug Eli Lilly's Mounjaro has become the top selling brand in the domestic pharma retail market with ...

The Indian stock market staged a solid comeback on Thursday after a weak start, driven by value buying and strong quarterly ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $34.5, a high ...

NEW DELHI : The Centre has extended the deadline for applying for the ₹ 5,000-crore Promotion of Research and Innovation in ...

Learn more about whether Arrowhead Pharmaceuticals, Inc. or BioMarin Pharmaceutical Inc. is a better investment based on AAII ...

Investing.com -- Oric Pharmaceuticals Inc (NASDAQ:ORIC) stock rose 1.9% in premarket trading Friday after the company published a peer-reviewed research paper on its cancer drug enozertinib in the ...

Indian pharmaceutical market records healthy 5-year CAGR of over 10 per cent: Our Bureau, Chennai Saturday, November 8, 2025, 08:00 Hrs [IST] The Indian Pharmaceutical Market (IPM ...

Eledon Pharmaceuticals stock was down 52.2% in pre-market trading on Friday, following a 1.74% rally yesterday. The shares ...

Analysts estimate that ARS Pharmaceuticals will report an earnings per share (EPS) of $-0.47. ARS Pharmaceuticals bulls will hope to hear the company announce they've not only beaten that estimate, ...

Learn more about whether ADMA Biologics, Inc. or BioMarin Pharmaceutical Inc. is a better investment based on AAII's A+ ...